» Articles » PMID: 30818329

Integration of Single-cell RNA-seq Data into Population Models to Characterize Cancer Metabolism

Overview
Specialty Biology
Date 2019 Mar 1
PMID 30818329
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic reprogramming is a general feature of cancer cells. Regrettably, the comprehensive quantification of metabolites in biological specimens does not promptly translate into knowledge on the utilization of metabolic pathways. By estimating fluxes across metabolic pathways, computational models hold the promise to bridge this gap between data and biological functionality. These models currently portray the average behavior of cell populations however, masking the inherent heterogeneity that is part and parcel of tumorigenesis as much as drug resistance. To remove this limitation, we propose single-cell Flux Balance Analysis (scFBA) as a computational framework to translate single-cell transcriptomes into single-cell fluxomes. We show that the integration of single-cell RNA-seq profiles of cells derived from lung adenocarcinoma and breast cancer patients into a multi-scale stoichiometric model of a cancer cell population: significantly 1) reduces the space of feasible single-cell fluxomes; 2) allows to identify clusters of cells with different growth rates within the population; 3) points out the possible metabolic interactions among cells via exchange of metabolites. The scFBA suite of MATLAB functions is available at https://github.com/BIMIB-DISCo/scFBA, as well as the case study datasets.

Citing Articles

A systems-level, semi-quantitative landscape of metabolic flux in C. elegans.

Zhang H, Li X, Tseyang L, Giese G, Wang H, Yao B Nature. 2025; .

PMID: 40011784 DOI: 10.1038/s41586-025-08635-6.


A physics informed neural network approach to quantify antigen presentation activities at single cell level using omics data.

Zhang C, Wang J, Dang P, Wei Y, Wang X, Brothwell J Res Sq. 2025; .

PMID: 39877095 PMC: 11774464. DOI: 10.21203/rs.3.rs-5629379/v1.


Metabolic complementation between cells drives the evolution of tissues and organs.

Pavlicev M, DiFrisco J, Love A, Wagner G Biol Lett. 2024; 20(11):20240490.

PMID: 39561800 PMC: 11583983. DOI: 10.1098/rsbl.2024.0490.


Intratumoral Heterogeneity and Metabolic Cross-Feeding in a Three-Dimensional Breast Cancer Culture: An In Silico Perspective.

Arellano-Villavicencio J, Vazquez-Jimenez A, Oropeza-Valdez J, Padron-Manrique C, Prado-Garcia H, Tovar A Int J Mol Sci. 2024; 25(20).

PMID: 39456679 PMC: 11508025. DOI: 10.3390/ijms252010894.


Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective.

Xiao Y, Li Y, Zhao H Mol Cancer. 2024; 23(1):202.

PMID: 39294747 PMC: 11409752. DOI: 10.1186/s12943-024-02113-9.


References
1.
Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

2.
Edwards J, Ibarra R, Palsson B . In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nat Biotechnol. 2001; 19(2):125-30. DOI: 10.1038/84379. View

3.
Famili I, Forster J, Nielsen J, Palsson B . Saccharomyces cerevisiae phenotypes can be predicted by using constraint-based analysis of a genome-scale reconstructed metabolic network. Proc Natl Acad Sci U S A. 2003; 100(23):13134-9. PMC: 263729. DOI: 10.1073/pnas.2235812100. View

4.
Mahadevan R, Schilling C . The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab Eng. 2003; 5(4):264-76. DOI: 10.1016/j.ymben.2003.09.002. View

5.
Price N, Reed J, Palsson B . Genome-scale models of microbial cells: evaluating the consequences of constraints. Nat Rev Microbiol. 2004; 2(11):886-97. DOI: 10.1038/nrmicro1023. View